These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30125579)

  • 1. Molecular mechanisms of glucocorticoid resistance in systemic lupus erythematosus: A review.
    Gao H; Wang Q; Yu X; Liu J; Bai S; Feng J; Wu B
    Life Sci; 2018 Sep; 209():383-387. PubMed ID: 30125579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between mRNA level of glucocorticoid receptor α, heat shock protein 90, protein level of macrophage migration inhibitory factor and glucocorticoid resistance in systemic lupus erythematosus].
    Guan Y; Zhang Y; Fang M; Guan J; Sun X; Zhang J
    Zhonghua Nei Ke Za Zhi; 2015 Nov; 54(11):922-6. PubMed ID: 26759210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent glucocorticoid resistance in systemic lupus erythematosus patients during clinical remission.
    Melo AK; Melo MR; Saramago AB; Demartino G; Souza BD; Longui CA
    Genet Mol Res; 2013 Jun; 12(2):2010-9. PubMed ID: 23479142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte sensitivity assay as a marker for glucocorticoid resistance in lupus: report of two sisters with systemic lupus erythematosus.
    Fajardo-Hermosillo LD; Rodríguez-Navedo Y; Nadal AJ; Vilá LM
    Lupus; 2014; 23(1):88-92. PubMed ID: 24285097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of glucocorticoid receptor isoforms and associations with serine/arginine-rich protein 30c and 40 in patients with systemic lupus erythematosus.
    Guan YC; Jiang L; Ma LL; Sun XN; Yu DD; Liu J; Qu DX; Fang MY
    Clin Exp Rheumatol; 2015; 33(2):225-33. PubMed ID: 25665148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunting Autoantigen-induced FOXO3a Protein Phosphorylation and Degradation Is a Novel Pathway of Glucocorticoids for the Treatment of Systemic Lupus Erythematosus.
    Lu M; Xu W; Gao B; Xiong S
    J Biol Chem; 2016 Sep; 291(38):19900-12. PubMed ID: 27481940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science.
    Luijten RK; Fritsch-Stork RD; Bijlsma JW; Derksen RH
    Autoimmun Rev; 2013 Mar; 12(5):617-28. PubMed ID: 23232124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
    Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
    Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative relationship between expression of glucocorticoid receptor alpha and disease activity: glucocorticoid treatment of patients with systemic lupus erythematosus.
    Li X; Zhang FS; Zhang JH; Wang JY
    J Rheumatol; 2010 Feb; 37(2):316-21. PubMed ID: 20032106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deescalation and glucocorticoid-free treatment in SLE].
    Fischer-Betz R; Schneider M
    Z Rheumatol; 2021 May; 80(4):332-338. PubMed ID: 33721043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience.
    Tani C; Elefante E; Signorini V; Zucchi D; Lorenzoni V; Carli L; Stagnaro C; Ferro F; Mosca M
    RMD Open; 2019; 5(2):e000916. PubMed ID: 31275608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus.
    Deng J; Chalhoub NE; Sherwin CM; Li C; Brunner HI
    Semin Arthritis Rheum; 2019 Oct; 49(2):251-259. PubMed ID: 30987856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prednisolone sensitivity of peripheral blood mononuclear cells of patients with systemic lupus erythematosus clinically resistant to glucocorticoids and the effects of carbon hemoperfusion].
    Petrova GN; Baranova FS; Popova LK; Dmitriev AA
    Ter Arkh; 1987; 59(8):107-10. PubMed ID: 3686432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional versus Rapid Glucocorticoid Tapering in Severe Systemic Lupus Erythematosus Patients: A Non-Blind, Randomized Controlled Trial.
    Abe Y; Fujibayashi K; Nishizaki Y; Yanagisawa N; Nojiri S; Kon T; Tada K; Yamaji K; Tamura N
    Acta Med Okayama; 2020 Apr; 74(2):179-183. PubMed ID: 32341595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus.
    Bertsias G; Askanase A; Doria A; Saxena A; Vital EM
    Rheumatology (Oxford); 2024 Jul; 63(7):1837-1849. PubMed ID: 38281071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids in systemic lupus erythematosus.
    Mosca M; Tani C; Carli L; Bombardieri S
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S126-9. PubMed ID: 22018198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased organ damage associated with deterioration in volumetric bone density and bone microarchitecture in patients with systemic lupus erythematosus on longterm glucocorticoid therapy.
    Tang XL; Zhu TY; Hung VW; Qin L; Wong CK; Kun EW; Tam LS; Li EK
    J Rheumatol; 2012 Oct; 39(10):1955-63. PubMed ID: 22896029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus.
    Kansal A; Tripathi D; Rai MK; Agarwal V
    Clin Rheumatol; 2016 Feb; 35(2):341-9. PubMed ID: 26415739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.